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The psychological adjustment of patients with psoriasis has been studied extensively. By comparison, no research
has focused on their partners. We examined illness representations of psoriasis held by patients and their partners,
and investigated whether divergent beliefs were associated with psychological distress. Fifty-eight patients with
chronic plaque psoriasis and their partners completed a range of psychological assessments including beliefs
about the condition, anxiety, depression, and worry. Patients also completed a self-assessment of psoriasis
severity. Patients with psoriasis had signiﬁcantly higher levels of anxiety, depression, and worry than their
partners (t’s4 2.53, p’so.05). Multiple regression analysis indicated that divergence in patients’ and partners’
beliefs about emotional impact of psoriasis and chronicity of timeline accounted for a statistically signiﬁcant
(21.3%) proportion of the variance in depression for partners. Differences in views on the consequences of having
psoriasis and the cyclical nature of the condition were also signiﬁcantly associated with increased levels of worry
in partners. Dissimilarity in particular aspects of illness representations are associated with increased
psychological distress in particular for the partners of patients with psoriasis. The results illustrate the importance
of concordance between patients’ and partners’ models of illness in relation to adjustment, and highlight the need
to consider and collaborate with both patients and their partners in managing this challenging condition.
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There is undeniable evidence that the impact and burden of
psoriasis can be substantial (Ginsburg and Link, 1989;
Gupta et al, 1993; Finlay and Coles, 1995; Fortune et al,
1997a, 2000, 2002a; Leary et al, 1998; Krueger et al, 2001;
Richards et al, 2001). Disability in psoriasis is comparable
with that found in patients with cancer, arthritis, hyperten-
sion, heart disease, diabetes, and depression (Rapp et al,
1999), and patients with psoriasis report more distress than
patients with other forms of skin disease such as vitiligo
(Porter et al, 1986) and fungal infections (Fava et al, 1980).
Furthermore, patients often feel stigmatized by their condi-
tion (Fortune et al, 1997b; Richards et al, 2001), and may
have to contend with stigma arising from uninformed public
attitudes about their psoriasis, as well as that which may
arise from such discrimination.
As with all illnesses, psoriasis does not occur in isolation.
Given the wide-ranging impact on individual patient’s lives,
it would seem unlikely that the patients’ families, especially
their partners, remain untouched. A partner may find their
social life curtailed, as the patient’s avoidance and
associated disability prevents them from engaging in
usually enjoyable activities; they may also be distressed
by the fact that their partner is suffering and may have to
deal with the negative effects that psoriasis can have on the
psychological health of the patient. All these problems can
be stressful for the well partner and may also place them at
risk for psychological and health problems (Kiecolt-Glaser
et al, 1995; Vedhara et al, 1999). Indeed, research in chronic
illness has found increased levels of depression in partners of
those with chronic pain (Flor et al, 1987), rheumatoid arthritis
(Walsh et al, 1999), renal disease (Rideout et al, 1990), and
heart disease (Croog and Fitzgerald, 1978). In order to
account for levels of distress in patients and partners,
researchers and clinicians have begun to investigate the
‘common-sense’ model of disease held by patients and
their partners. The main question addressed in this study is
whether and to what extent are differences in the common-
sense model of psoriasis held by patients and their partners
related to psychological outcome for both parties.
Empirical literature suggests that in order to understand
and respond to the difficulties presented by illness, patients
construct their own common-sense model of their condition
(Leventhal et al, 1980, 1992). These beliefs about a disease
are formed around a number of dimensions of the illness
experience: (i) illness identity (symptoms associated with
the condition); (ii) chronicity or recurrence of the condition;
(iii) consequences of the condition; (iv) personal and
treatment control; (v) illness coherence (understanding of
the condition); (vi) patients’ emotional response to their
condition; and (vii) causes of the condition (Fig 1). These
Abbreviations: IPQ-R, Illness Perception Questionnaire-Revised;
SAPASI, Self-Assessment Psoriasis Area Severity Index
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beliefs or illness representations are said to drive attempts
to cope with illness and have a significant impact on
adjustment to illnesses (Petrie et al, 1996; Murphy et al,
1999). Within psoriasis, illness representations have been
demonstrated to be the most consistent predictor of stress,
distress, and disability in patients (Fortune et al, 2002a), and
are associated with increased use of outpatient services
(Scharloo et al, 2000). Moreover, a growing body of research
demonstrates that beliefs about illness held by significant
others in relation to the patient can also have an impact on
the well-being of that individual, especially if those beliefs
diverge (Heijmans et al, 1999). There exists the potential for
spouses of patients with psoriasis to underestimate the
consequences of a condition such that the patient feels
misunderstood, or to overestimate the consequences and
become overprotective and encourage increased depen-
dency by the patient. Furthermore, illness beliefs have been
shown to account for more of the distress in carers than
objective physical correlates of the partner’s condition
(McClenahan and Weinman, 1998).
No research has been conducted, to date, on partners of
individuals with psoriasis. Thus we investigated the illness
representations of psoriasis held by psoriasis patients and
their well partners, and examined how their differences in
beliefs about psoriasis may be associated with adaptive
outcome in terms of anxiety, depression, and worry.
Results
Participants Fifty-eight patients with chronic plaque psor-
iasis and their partners completed a range of questionnaires
assessing psychosocial factors. The mean age of the
psoriasis population was 44 (  12) years. The mean age
of onset of psoriasis was 26 (  16) years, and the duration
of psoriasis was 18 years (  11); 49% of patients were
male. The mean SAPASI was 12.3 (  10.5) and ranged from
0.9 to 48.1. At the time of the study, 65% of patients were
employed. The mean age of the partners was 47 (  13)
years, 74% were employed, and 51% were male. Using the
United Kingdom Office of National Statistics Classifications
(ONS, 2001), patient–partner dyads were consistent with the
following socio-economic classes: Social Class 1¼8.7%;
Social Class 2¼37%; Social Class 3¼ 13%; Social Class
4¼2.2%; Social Class 5¼8.7%; Social Class 6¼ 15.2%;
Social Class 7¼10.9%; and Social Class 8¼4.3%.
Patients’ and partners’ psychological distress Mean
scores were calculated for levels of psychological distress
in patients and their partners. Independent t tests indicated
that patients had significantly higher levels of anxiety
(t¼2.65, po.01), depression (t¼ 2.53. po.05), and patho-
logical worry (t¼ 2.85, po.01) than their partners (Table 1).
We also examined the number of patients and partners
whose scores placed them in the category of probable
mood disorder. Table 2 illustrates these results in compar-
ison with those reported in previous studies.
Gender differences Independent t test analysis indicated no
difference between males and females on any clinical or
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Figure 1
Common-sense model of dissimilarity in psoriasis representation held by patients and their partners.
Table 1. Mean scores (standard deviation) for anxiety,
depression, and worry in psoriasis patients and well partners
Patient Partner
HADS anxiety 7.60 (  3.98) 5.63 (  4.00)a
HADS depression 4.55 (  3.53) 3.02 (  2.90)b
PSWQ 47.47 (  11.90) 40.33 (  14.86)a
aSignificant difference between well partners and patients at po0.01.
bSignificant difference between well partners and patients at po0.05.
HADS, Hospital Anxiety and Depression Scale; PSWQ, Penn State
Worry Questionnaire.
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demographic variable (t’s o.97, p’s40.33). Independent
t tests indicated that there were no significant differences
between male and female patients in their levels of
psychological distress (t¼o1.03, p40.3). Female part-
ners, however, had significantly greater levels of anxiety
(t¼2.74, po0.01) and worry (t¼3.55, po0.001) than
their male counterparts.
General differences between patients’ and partners’
beliefs about psoriasis Prior to the examination of dissimi-
larity in patient–partner dyads, differences in illness repre-
sentations between patients and partners overall were exa-
mined. Multivariate analysis of variance indicated no
significant differences between the beliefs that patients
and spouses held (F’so2.03, p’s40.16). Thus, overall,
patients and partners held very similar beliefs about
psoriasis. Table 3 presents the adjusted mean scores and
standard deviations for the different dimensions of illness
representations for psoriasis patients and their partners.
Dissimilarity between illness representations
held by patients and partners
Beliefs about causes of psoriasis Patients’ views of causal
attributions of psoriasis were used as the criterion, and
partners’ scores were compared against these and coded in
terms of agreement, minimization, and maximization for
individual cause items. The percentages of patient–partner
pairs minimizing and maximizing on each of the individual
causes are illustrated in Fig 2.
Partners of patients with psoriasis were inclined to
maximize etiological roles for stress, poor medical care,
and overwork relative to patients and to minimize aging,
alcohol, smoking, family problems, accident, patients’ own
behavior, mental attitude, chance, pollution, diet, and germ/
virus as causes of patients’ psoriasis.
Symptoms experienced as part of psoriasis The level of
agreement on individual symptoms that patients and
partners associated with psoriasis was also examined. In
general, there was consensus between patients and their
partners on the symptoms associated with psoriasis.
Patients and their partners showed least agreement on
pain, stiff joints, skin burning, and sleep difficulties, with
partners tending to maximize all these symptoms with the
exception of sleep difficulties, which were minimized. Most
agreement was in relation to itching, skin flaking, and
changes in weight (Table 4).
Associations between dissimilarity scores and psycho-
logical distress Dissimilarity scores were computed for
the remaining illness representation categories (Table 5),
and in order to examine whether divergent views on the
representation of illness could help explain outcome in
Table 2. Data from comparable studies on patients and well partners as cases for anxiety, depression, and pathological worrying
Psoriasis patient
(n¼58) (%)
Well partner
(n¼58) (%)
Comparative—psoriasisa,b
(n¼ 115a; n¼140b) (%)
Comparative—controlc
(n¼60) (%)
Probable anxiety 27.6 10.3 43a 4c
Probable depression 10.3 1.7 10a 0c
Pathological worry 15.5 10.3 38b 11c
aRichards et al (2001a).
bFortune et al (2000).
cFortune et al (2003a,b).
Table 3. Adjusted mean scores (standard deviation) of
patients’ and partners’ ratings on different dimensions of
illness representations
Dimension Patient (n¼58) Well partner (n¼58)
Illness identity 5.43 (  2.72) 5.63 (  3.15)
Timeline 4.13 (  0.60) 3.90 (  0.74)
Consequences 3.34 (  0.82) 3.30 (  0.76)
Personal control 3.20 (  0.83) 3.04 (  0.79)
Treatment control 3.55 (  0.56) 3.43 (  0.65)
Illness coherence 3.26 (  1.15) 3.57 (  0.95)
Timeline—cyclical 3.43 (  0.75) 3.41 (  0.80)
Emotional representation 3.19 (  0.84) 2.85 (  0.82)
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Figure2
Percentage of partners maximizing’ and minimizing& individual
beliefs about causes of psoriasis.
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psoriasis patients and their partners, a series of hierarchical
multiple regression analyses were undertaken, predicting in
turn psoriasis-related disability (for patients only), anxiety
depression, and worry. The order of entry of the variables
into the equations was assigned so as to permit the
investigation that divergence in illness representations will
account for unique variance in psychological outcome
(anxiety, depression, worry, and disability) over and above
demographic and physical variables. Firstly, to determine
the entry of variables into the final regression equations, at
stage 1 for each of the outcome variables (disability, worry,
anxiety, and depression), predictor variables were entered
individually into the regression equation to see if they were
independently related to the dependent variable of interest.
The variables included in the analysis included: demo-
graphic variables of age and gender; clinical history
variables of duration of psoriasis and age at onset; physical
findings of SAPASI; and divergence in illness perceptions of
illness identity, causes, personal control, treatment control,
consequences, illness coherence, emotional representa-
tions, timeline chronic, and timeline cyclical.
Psoriasis patients From the initial examination of regres-
sions for the above variables as independent predictors of
anxiety, depression, worry, and disability, it was found that
the independent predictor variables did not account for any
significant proportion of the variance in terms of anxiety,
depression, or disability. The demographic variables of age
and divergence in beliefs about emotional representations
were, however, found to predict a significant proportion of
the variance in worry. At stage 2 only those variables that
were significantly associated with worry from this analysis
were retained and entered into the regression analysis. Thus
the demographic variable of age was entered in block one
and the divergent belief about emotional representations
was retained for entry at block 2. The results are presented
below in Table 6, and significant b values are in bold.
The results indicate that divergence in illness beliefs did
not make a significant contribution to the variance in worry
in psoriasis patients, over and above the age of the patient.
Partners The predictor variables (age of partner, gender of
partner, severity of patients psoriasis, and divergence in
illness beliefs) were individually regressed onto each of the
dependent variables for the partner (anxiety, depression,
worry). In relation to anxiety, no variables were significantly
associated with anxiety with the exception of gender
(F1,54¼10.72, po.01).
Initial examination of predictor variables in relation to
depression indicated that both dissimilarity in emotional
representations and timeline (acute/chronic) representa-
tions were independently associated with depression.
Following the stage 2 analysis, both these variables
accounted for 21.3% of the variance in depression and
both standardized regression coefficients reached signifi-
cance (Table 7).
The independent contribution of the predictor variables
in relation to worry in partners was examined and indicated
that gender, divergence in beliefs about consequences, and
in beliefs about the cyclical nature of psoriasis were signi-
ficantly associated independently with worry in partners.
These statistically significant variables were moved to stage
2 of the analysis and entered in blocks into the regression
equation. The results of this are presented in Table 8. Gen-
der accounted for 17.2% of the variance and divergence
in beliefs relating to consequences and cyclical timeline
contributed an additional 24.8% of the variance in worry
scores, with significant standardized regression coefficients
for gender and consequences. This suggests that for well
partners, gender and divergence in beliefs about conse-
quences may be important as risk factors in worry.
Table 4. Percentage of well partners agreeing, maximizing,
and minimizing the symptoms associated with their
partners’ psoriasis
Symptom
Agreement
(%)
Maximizing
(%)
Minimizing
(%)
Pain 68.5 18.5 13
Stiff joints 63.6 18.2 18.2
Skin burning 70.4 16.7 13
Fatigue 76.4 14.5 9.1
Upset stomach 83.6 12.7 3.7
Nausea 83.9 12.5 3.6
Sleep difficulties 73.6 11.3 15.1
Headaches 82.5 10.5 7
Breathlessness 89.1 7.3 3.6
Dizziness 89.4 7.1 3.5
Wheeziness 92.9 7.1 0
Loss of strength 83.6 5.5 10.9
Sore eyes 91.1 5.3 3.6
Sore throat 87.5 1.8 10.7
Weight loss 100 0 0
Skin itching 100 0 0
Skin flaking 98.2 0 1.8
Table 5. Percentage of partners maximizing and minimizing on
various illness belief dimensions in relation to the patient
Nature of
dissimilarity
Agreement
(%)
Maximizing
(%)
Minimizing
(%)
Timeline 70 18 12
Consequences 66 19 15
Personal control 72 14 14
Emotional impact 59 19 22
Treatment control 73 17 10
Illness coherence 72 12 16
Timeline cyclical 70 11 19
Illness identity
(symptoms)
74 4 22
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Discussion
This study examines psychological distress in partners of
patients with psoriasis, and shows how areas of dissim-
ilarity between the illness representations held by patients
and their partners are associated with psychological
outcomes of depression and worry.
The study illustrates that when compared as two groups,
patients and partners had very similar beliefs about
psoriasis. Dissimilarity between patient and partner dyads
on psoriasis beliefs, however, was related to psychological
distress, in particular, for the partners of patients. There is a
substantial body of evidence to suggest that the emotional
impact of psoriasis is significant (Fortune et al, 2000;
2002a–c; Richards et al, 2001); however, the results of this
study in relation to dissimilarity in illness representations
suggest that this is not being recognized by partners and
makes a significant contribution to partner levels of distress.
It is well established that patients with psoriasis feel
stigmatized by their condition (Ginsburg and Link, 1989;
Richards et al, 2001). It may be that in the same way that
individuals with psoriasis may avoid social situations for fear
of the negative responses of others (Fortune et al, 1997),
they also conceal the emotional impact of their psoriasis
from their partners. Indeed, the stigma that accompanies
many mental health problems often impedes seeking help.
Recognition of such conditions and the difference between
views held by patients and their partners can be seen to be
congruent with this. Indeed, recent work has shown that
patients with psoriasis use social support strategies, such
as gaining sympathy or emotional support less frequently
than control subjects (Fortune et al, 2002b). This suggests
avoidance of engaging in strategies that may be helpful
both in terms of coping and enhancing a partner’s under-
standing of psoriasis.
Further substantiation of this thesis is enhanced by the
finding that dissimilarity in emotional representations was in-
dependently associated with worrying for psoriasis patients.
This has a number of implications. As we have previously
reported (Fortune et al, 2003b), psychological distress in
the form of excessive worrying is the principal predictor of
time taken for photochemotherapy to clear psoriasis. Thus,
it may be that a mismatch in beliefs surrounding the
emotional impact of the condition and potentially avoiding
disclosure of this emotional distress may have an impact on
both psychological and clinical outcomes.
Although there was no significant difference between the
number of symptoms (illness identity) that patients and their
partners associated with psoriasis, there was disagreement
over the types of symptoms experienced. This dichotomy
was associated with increased depression in patients, a
finding that lends credence to the suggestion that patients
are not disclosing the physical aspects of the disease to
their partners, thereby contributing to the divergence in
beliefs. These results suggest that not only do patients feel
they need to hide the physical symptoms of psoriasis but
also the emotional difficulties associated with the condition.
Worry in well partners was associated with greater maxi-
mization of the consequences associated with having psori-
asis. This is perhaps to be expected. If an individual’s concerns
about negative consequences associated with a condition
are not matched by those of their ill partner, it is likely that they
will engage in rumination in an attempt to prevent or avoid
potential catastrophy related to such consequences. Worrying
by partners may thus be viewed as an unhelpful coping
strategy to help them manage with the uncertainties asso-
ciated with the consequences of their partner’s condition.
In this study, partners were found to have significantly
lower levels of psychological distress compared with
patients with psoriasis, which is at variance with research
in other chronic conditions (Croog and Fitzgerald, 1978;
Flor et al, 1987; Walsh et al, 1999; Rideout et al, 1990). This
Table 6. Regression analysis testing the signiﬁcance of change in explained variance on worry in patients with psoriasis
Variables Adjusted R2 (%) R2 change (%) F p b
Demographic
Age
16.3 17.9 11.14 o0.01 0.37
Illness beliefs
Emotional representations
16.7 2.0 1.23 0.27 0.15
Table 7. Regression analysis testing the signiﬁcance of
change in explained variance on depression in partners of
patients with psoriasis
Variables
Adjusted
R2 (%)
R2
change
(%) F p b
Illness beliefs 18.0 21.3 6.37 o0.01
Emotional
representations
0.35
Timeline
(acute/chronic)
0.30
Table 8. Regression analysis testing the signiﬁcance of
change in explained variance on worry in partners of
patients with psoriasis
Variables
Adjusted
R2
(%)
R2
change
(%) F p b
Demographic
Gender 15.3 17.2 9.12 o0.01 0.44
Illness beliefs 37.8 24.8 8.98 o0.001 —
Cyclical
representations
0.08
Consequences 0.41
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finding may reflect the non-life-threatening nature of
psoriasis. Furthermore, if patients are concealing both the
symptoms and the distress they experience from their
significant others, this may also contribute to reduced levels
of distress in the partner cohort.
There are a number of limitations to this study that should
be considered. Firstly, as both patient and partner had to
consent to participate it may be that only those couples
who felt relatively confident in their relationship agreed to
participate. Thus it may be that the results presented here
are an underestimation of dissimilarities in understanding
psoriasis and the distress associated with it for both
patients and partners. Secondly, as patients and partners
did not complete questionnaires in the presence of the
researcher, it is possible that collusion took place in terms of
completion of questionnaires and responses to items. But
the lack of agreement on the symptoms associated with the
condition and emotional representations suggests other-
wise. Thirdly, as a cross-sectional study it is not possible to
determine directionality or causality definitively. It remains
conceivable that depression and worry in patients or their
partners may contribute to lack of agreement. Indeed,
recent studies have demonstrated the positive impact of
group cognitive behavioral therapy on both psychological
(anxiety and depression) and physical severity (Psoriasis
Area and Severity Index) in the management of psoriasis
(Fortune et al, 2002c). Such improvements were also in line
with changes in illness representations for patients, parti-
cularly those concerning the consequences of their condi-
tion, illness identity, and attributions for emotional causes
of their condition (Fortune et al, 2004). As such, further
longitudinal studies are clearly required to substantiate this
hypothesis. One further limitation is the absence of a
description of the longevity of the relationship or an esti-
mation of the quality of the relationship. This is potentially an
area of importance, and we are currently undertaking an
examination of such at present, focusing on the degree of
criticism within the relationship, which may be perceived as
contributing to everyday stress. Clearly, further research will
be well placed, examining the families and partners of
individuals with psoriasis.
This study offers an insight into the way in which diver-
gence, in terms of the way psoriasis is thought about by
patient and partner, may have an impact on psychological
and clinical outcome. Furthermore, the potential importance
of working with psoriasis patients within their psychosocial
environment, that is, including their partner has been high-
lighted. Indeed, interventions involving partners have pro-
ved useful for both patients and partners in other chronic
conditions including pain (Keefe et al, 1996), rheumatoid ar-
thritis (Radojevic et al, 1992), and cardiac illness (Daugherty
et al, 2002). Moreover, the results illustrate the importance
of concordance between patients’ and partners’ models of
psoriasis in relation to adjustment, and highlight the need to
consider and collaborate with both patients and their
partners in managing this challenging condition.
Methods
Design Cross-sectional study of patients with psoriasis and their
partners.
Subjects The subjects consisted of patients with a dermatologist-
confirmed diagnosis of chronic plaque psoriasis and their partners.
All psoriasis patients were recruited either from a psoriasis spe-
cialty clinic, general dermatology outpatient clinics, or an inpatient
ward setting. Patients were eligible to participate if they agreed to
their partner being involved in the study, the couple was living
together in a committed relationship, and the partner had no other
general medical condition. All patients and partners were English
speaking and provided written informed consent.
Procedure Psoriasis patients and their partners were instructed to
complete the questionnaires independently and return them to the
investigator in two separate self-addressed stamped envelopes.
These questionnaires assessed various aspects of the patients’
and partners’ psychological and social functioning. In addition,
demographic data and self-report information on the patients’
psoriasis were collected. The study was approved by Salford and
Trafford Local Research Ethics Committee.
Measures The following measures were completed by each
patient with psoriasis:
(1) Self-Assessment Psoriasis Area Severity Index (SAPASI; Feld-
man et al, 1996) comprises a single page questionnaire of an
anterior and posterior silhouette of a body for the subject to
shade areas affected by psoriasis and three visual analogue
scales to indicate the degree of redness, scaling, and thickness
of an average lesion. This provides an estimate of the physical
severity of psoriasis. The SAPASI has been reported to be
reliable and valid and correlate with standardized clinician-
rated scales (Fleischer et al, 1994, 1996).
(2) Hospital Anxiety and Depression Scale (HADS; Zigmond and
Snaith, 1983) is a 14-item scale providing an assessment of
symptoms of anxiety and depression and is suitable for use in
medical and surgical patients. Items are rated on a 0–3 point
scale indicating the strength of agreement with each item. A
score of X11 on either the anxiety or depression subscale of
the HADS is representative of a high probability of suffering
from anxiety or depression. Good reliability and validity co-
efficients have been reported (Lewis and Wessely, 1990).
(3) Penn State Worry Questionnaire (PSWQ) is a 16-item self-
report scale purporting to measure the strength of pathological
worry. Scores of above 60 are indicative of pathological worry.
It has been demonstrated to be psychometrically sound with
good test–re-test reliability (r¼ 0.93; Meyer et al, 1990; Davey,
1993) and high internal consistency in psoriasis (Cronbach’s
a¼ 0.93; Fortune et al, 2000).
(4) The Illness Perceptions Questionnaire-Revised (IPQ-R; Moss-
Morris et al, 2002) provides a theoretically based measure of
patients’ beliefs about their condition, which is suitable for use
in any patient population. The original questionnaire (IPQ;
Weinman et al, 1996) was recently revised to improve the
psychometric properties of the original instrument and incor-
porate a number of previously neglected additional compo-
nents of a patient’s implicit model of illness. The IPQ-R includes
seven sub-scales (38 items), which attempt to operationalize
the components of the common-sense model of illness held by
patients. These subscales assess perceptions about how long
psoriasis will last (‘‘timeline’’; six items including ‘‘My psoriasis
will last a short time,’’ ‘‘My psoriasis is likely to be permanent
rather than temporary.’’); beliefs in the consequences asso-
ciated with the condition (six items including: ‘‘My psoriasis has
had major consequences on my life,’’ ‘‘My psoriasis causes
difficulties for those who are close to me’’); beliefs about
personal control (six items including: ‘‘There is a lot which I can
do to control my symptoms’’; ‘‘Nothing I do will affect my
psoriasis’’) and treatment control (5 items including: ‘‘My
treatment can control my psoriasis’’; ‘‘There is nothing which
can help my psoriasis’’); the individual’s understanding of their
condition (illness coherence; five items including: ‘‘The symp-
toms of my condition are puzzling to me’’; ‘‘I have a clear
picture or understanding of my condition’’); beliefs about
the cyclical nature of the condition (four items including
‘‘My psoriasis is very unpredictable’’, ‘‘The symptoms of
my psoriasis change a great deal from day to day’’); and the
emotional representations associated with the illness (six items
including: ‘‘I get depressed when I think about my psoriasis’’;
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‘‘My psoriasis does not worry me’’). An adjusted mean score
(sum of the scale items divided by the number of items) is
calculated for each of the sub-scales outlined above, with a
possible maximum of 5 for each sub-scale.
Illness identity or symptoms experienced since the onset of the
condition is assessed by 17 items, including pain, stiff joints, skin
burning, skin itching, and skin flaking. Individuals are required to
respond affirmatively or not to the existence of such symptoms in
relation to their condition.
The final scale of the IPQ-R measures personal ideas about the
cause of psoriasis. The scale requires patients to identify what they
believe is responsible for onset or exacerbations of their condition.
Items are assumed to be independent and as such are not
summed to form a total score. Eighteen causes of the illness are
identified, including stress or worry, hereditary, my immunity, my
personality, and aging, and these are scored on a five-point scale
from 1 (‘strongly disagree’) to 5 (‘strongly agree’).
The spouse or partner was required to complete the same
psychometric assessments as the patient with psoriasis with the
exception of the SAPASI. They also completed a spouse/partner
version of the IPQ-R. The partner version of the IPQ and IPQ-R has
been used in a number of studies (Heijmans et al, 1999; Barrow-
clough, Lobban, Hatton & Quinn, 2001), whereby items are phrased
to ascertain the partners’ perception of their spouses psoriasis, for
example, ‘‘My partners psoriasis is very unpredictable’’; ‘‘My partners
actions will have no affect on the outcome of their psoriasis’’.
Calculation of dissimilarity scores Dissimilarity scores (Heij-
mans et al, 1999) were calculated for each of the illness percep-
tions’ dimensions. For the seven subscales of the IPQ-R, these
were achieved by subtracting partners’ scale scores from psoriasis
patients’ scale scores, thereby creating a continuous variable
representing the direction of difference from the patient’s belief.
Subsequently, for each of the subscales, the mean and standard
deviation (SD) in dissimilarity scores were calculated. In order to
account for normal variability between patients and partners
scores, those scoring within 1 SD either side of the mean for that
scale were classified as congruent, those less than 1 SD as mini-
mizing, and more than 1 SD maximizing for that particular scale.
In relation to the illness-identity scale (symptoms associated
with psoriasis), agreement on the number of symptoms experi-
enced as well as agreement on which particular symptoms were
experienced was calculated.
For the ‘‘cause’’ subscale, scores relating to agreement,
minimization, or maximization were calculated for individual causal
items. Thus overall, partners’ scores that were less than those of
the patients on particular representations were termed ‘minimizing’
(i.e., the partner did not believe that particular aspect to be as
significant as the patient reported) and partners’ scores that were
greater were termed ‘‘maximizing’’ (i.e., the partner believed the
impact to be greater than the patient reported). All correlations
were calculated using these dissimilarity scores.
Statistical analysis Data were analyzed using SPSS. Indepen-
dent t test models were used to examine the differences between
psychological distress variables in patients and their partners.
Multivariate analysis of variance was used to examine differences
in illness beliefs between patients and partners. Kendall’s tau (t)
correlation coefficient was used to examine associations between
dissimilarity in illness beliefs between patients and partners and
their association with psychological distress. Values are presented
as mean  SD.
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